47.288356, 7.939630
Siegfried
Zofingen, Switzerland
- Verified lead
- Marcel Imwinkelried
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
- Review cycle
- May 2026
- Full address
- Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland
- Site coordinates
- 47.288356, 7.939630
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Siegfried leadership page confirming Marcel Imwinkelried as CEO.
- Editorial note
- Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
GMP manufacturing network, Multi-site pharmaceutical quality systems
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
Siegfried
CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply · Global CDMO manufacturing
Verified 14 Mar 2026 · 3 sources
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
- Website
- siegfried.ch
- Company page
- Lead
- Marcel Imwinkelried (verified ↗)
- Compliance
- GMP manufacturing network
- Last reviewed
- 14 Mar 2026 (4mo ago)
- Scale
- Global CDMO manufacturing
- Capabilities
- API Manufacturing · Finished-Dose Production · CDMO Supply Operations
- Founded
- 1873
- Headcount
- 1001-5000
CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
Verification details
Marcel Imwinkelried
Chief Executive Officer
Official Siegfried Zofingen location page listing Untere Brühlstrasse 4, Zofingen.
Open sourceGlobal CDMO manufacturing
Zofingen, Switzerland. CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply. Review completed on 14 Mar 2026.
Swiss, EU, and global pharmaceutical manufacturing oversight
GMP manufacturing network, Multi-site pharmaceutical quality systems
Capabilities
Sources
The official sources used to verify this profile.
Infrastructure
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
Frequently asked questions
- Where is Siegfried located?
- Siegfried operates from Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland, Zofingen, Switzerland.
- Who runs Siegfried?
- Siegfried is led by Marcel Imwinkelried, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Siegfried hold?
- Siegfried is documented under GMP manufacturing network.
- What does Siegfried do?
- Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile. Core capabilities: API Manufacturing, Finished-Dose Production, CDMO Supply Operations.
Related technical briefs
Briefs that name Zofingen as a covered market or city.
